BioNTech Plans to Initiate the Clinical Study of Malaria and Tuberculosis Vaccines in 2022
Shots: BioNTech unveils the plan to develop the first mRNA-based vaccine to prevent malaria with anticipated initiation of the clinical study by the end of […]